1222186-26-6 (GO 203,GO-203 TFA)

穿膜抑制肽;

s8674;H-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Cys-D-Gln-D-Cys-D-Arg-D-Arg-D-Lys-D-Asn-OH;GO-203 TFA;H-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Cys-D-Gln-D-Cys-D-Arg-D-Arg-D-Lys-D-Asn-OH.TFA;CCG-270700;AKOS040754598;DA-53668;DTXSID20989843;G69059;D-Arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-cysteinyl-D-glutaminyl-D-cysteinyl-D-arginyl-D-arginyl-D-lysyl-D-asparagine trifluoroacetic acid (1:1);GO203 TFA salt;1222186-26-6;GO-203;

WIUOAIBLROIIFP-BHDSHVNUSA-N

1S/C87H170N52O19S2.C2HF3O2/c88-28-2-1-15-44(71(152)137-56(76(157)158)40-60(91)141)126-63(144)46(17-5-31-116-79(96)97)133-70(151)53(24-12-38-123-86(110)111)135-74(155)57(41-159)139-73(154)55(26-27-59(90)140)136-75(156)58(42-160)138-72(153)54(25-13-39-124-87(112)113)134-69(150)52(23-11-37-122-85(108)109)132-68(149)51(22-10-36-121-84(106)107)131-67(148)50(21-9-35-120-83(104)105)130-66(147)49(20-8-34-119-82(102)103)129-65(146)48(19-7-33-118-81(100)101)128-64(145)47(18-6-32-117-80(98)99)127-62(143)45(16-4-30-115-78(94)95)125-61(142)43(89)14-3-29-114-77(92)93;3-2(4,5)1(6)7/h43-58,159-160H,1-42,88-89H2,(H2,90,140)(H2,91,141)(H,125,142)(H,126,144)(H,127,143)(H,128,145)(H,129,146)(H,130,147)(H,131,148)(H,132,149)(H,133,151)(H,134,150)(H,135,155)(H,136,156)(H,137,152)(H,138,153)(H,139,154)(H,157,158)(H4,92,93,114)(H4,94,95,115)(H4,96,97,116)(H4,98,99,117)(H4,100,101,118)(H4,102,103,119)(H4,104,105,120)(H4,106,107,121)(H4,108,109,122)(H4,110,111,123)(H4,112,113,124);(H,6,7)/t43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-;/m1./s1

SC[C@H](C(N[C@@H](C(N[C@H](CS)C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(=O)O)CC(N)=O)=O)CCCCN)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)=O)CCC(N)=O)=O)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)NC([C@@H](CCCNC(=N)N)N)=O)=O)=O)=O)=O)=O)=O)=O)=O.FC(C(=O)O)(F)F